What is new and ground-breaking about EQIPD research?
While common guidelines and standards exist regarding the reporting of preclinical research and drug-safety studies, no such guidelines or generally agreed-upon principles exist regarding the design, conduct and analysis of such research. The EQIPD project will develop guidelines for the initial stages of preclinical research and drug-safety studies, and aims to speed up the alarmingly slow pace of novel drug development.
The EQIPD project uses a multidisciplinary approach, comparing study design variables and data analysis variables from both industry and academia regarding their effect on a successful outcome.
Feasibility of such new guidelines and quality management will be tested in actual studies.
Which medical fields will particularly benefit from the EQIPD research and how?
While the majority of research for the EQIPD project will be conducted in the field of Neuroscience, it is anticipated that the principles discovered will apply broadly and R&D-wide.
Furthermore, an online educational platform will provide generalized education and training in the newly developed guidelines for design, conduct and analysis of preclinical research and drug-safety studies that is applicable to other fields of biomedical research and drug development as well.